Iovance Biotherapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Iovance Biotherapeutics's balance sheet done over the years? Its assets were worth $780,351,000 last year, which is more than in the previous period. 25% of Iovance Biotherapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $195,738,000, which means an increase by 19% compared compared to last year.
Debt to Assets
| 2014 | 46506847 | 1.66M | 3.57% |
|---|---|---|---|
| 2015 | 105653000 | 1.63M | 1.54% |
| 2016 | 171886000 | 4.96M | 2.89% |
| 2017 | 155373000 | 9.89M | 6.37% |
| 2018 | 480821000 | 14.62M | 3.04% |
| 2019 | 344655000 | 45.68M | 13.25% |
| 2020 | 768458000 | 111.96M | 14.57% |
| 2021 | 777333000 | 155.67M | 20.03% |
| 2022 | 663982000 | 164.34M | 24.75% |
| 2023 | 780351000 | 195.73M | 25.08% |
IOVA Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 114.88M | 231.73M | 78.22M | 67.32M | 13.96M | 82.15M | 145.37M | 166.47M | 103.7M | 44.90M |
Short term investments | 164.97M | 240.11M | 426.18M | 562.10M | 293.11M | 386.37M | 0 | 59.75M | 90.05M | 0 |
Net receivables | 151K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory | 10.37M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other current assets | 17.45M | 7.27M | 3.54M | 6.66M | 9.41M | 6.85M | 7.83M | 3.04M | 554K | 132.13K |
Total current assets | 307.84M | 471.84M | 507.95M | 636.1M | 312.53M | 475.37M | 149.29M | 169.51M | 103.97M | 44.97M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 176.54M | 178.24M | 169.92M | 113.91M | 19.23M | 2.68M | 2.45M | 2.37M | 1.67M | 1.53M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 229.25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 6.43M | 91.58M | 5.52M | 5.45M | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 66.7M | -178.24M | 7.86M | 12.91M | 7.44M | 2.76M | 3.63M | 0 | 0 | 0 |
Total non-current assets | 472.50M | 6.43M | 269.37M | 132.35M | 32.12M | 5.44M | 6.08M | 2.37M | 1.67M | 1.53M |
Total assets | 780.35M | 663.98M | 777.33M | 768.45M | 344.65M | 480.82M | 155.37M | 171.88M | 105.65M | 46.50M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Short term debt | 15.55M | 12.58M | 5.05M | 6.28M | 7.25M | 0 | 0 | 0 | 0 | 0 |
Total current liabilities | 110.30M | 91.48M | 89.2M | 54.87M | 39.08M | 14.39M | 9.89M | 4.96M | 1.63M | 1.66M |
| Non-current liabilities: | ||||||||||
Long term debt | 68.08M | 84.44M | 66.47M | 45.37M | 4.24M | 0 | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 0 | 0 | 11.71M | 2.35M | 230K | 296.99K | 0 | 0 | 0 |
Total non-current liabilities | 85.43M | 84.44M | 66.47M | 57.08M | 6.6M | 230K | 296.99K | 0 | 0 | 0 |
Total liabilities | 195.73M | 164.34M | 155.67M | 111.96M | 45.68M | 14.62M | 9.89M | 4.96M | 1.63M | 1.66M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |